418 related articles for article (PubMed ID: 21499429)
1. Preparation, characterization and targeting of micronized 10-hydroxycamptothecin-loaded folate-conjugated human serum albumin nanoparticles to cancer cells.
Li Q; Liu C; Zhao X; Zu Y; Wang Y; Zhang B; Zhao D; Zhao Q; Su L; Gao Y; Sun B
Int J Nanomedicine; 2011; 6():397-405. PubMed ID: 21499429
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and Tissue Distribution of Folate-Decorated Human Serum Albumin Loaded With Nano-Hydroxycamptothecin for Tumor Targeting.
Wang W; Liang H; Sun B; Xu J; Zeng Z; Zhao X; Li Q
J Pharm Sci; 2016 Jun; 105(6):1874-1880. PubMed ID: 27129905
[TBL] [Abstract][Full Text] [Related]
3. Preparation of 10-hydroxycamptothecin-loaded glycyrrhizic acid-conjugated bovine serum albumin nanoparticles for hepatocellular carcinoma-targeted drug delivery.
Zu Y; Meng L; Zhao X; Ge Y; Yu X; Zhang Y; Deng Y
Int J Nanomedicine; 2013; 8():1207-22. PubMed ID: 23569373
[TBL] [Abstract][Full Text] [Related]
4. Preparation, characterization, and in vitro targeted delivery of folate-decorated paclitaxel-loaded bovine serum albumin nanoparticles.
Zhao D; Zhao X; Zu Y; Li J; Zhang Y; Jiang R; Zhang Z
Int J Nanomedicine; 2010 Sep; 5():669-77. PubMed ID: 20957218
[TBL] [Abstract][Full Text] [Related]
5. Interaction of folate-conjugated human serum albumin (HSA) nanoparticles with tumour cells.
Ulbrich K; Michaelis M; Rothweiler F; Knobloch T; Sithisarn P; Cinatl J; Kreuter J
Int J Pharm; 2011 Mar; 406(1-2):128-34. PubMed ID: 21185364
[TBL] [Abstract][Full Text] [Related]
6. Folate receptor alpha targeted delivery of artemether to breast cancer cells with folate-decorated human serum albumin nanoparticles.
Akbarian A; Ebtekar M; Pakravan N; Hassan ZM
Int J Biol Macromol; 2020 Jun; 152():90-101. PubMed ID: 32057865
[TBL] [Abstract][Full Text] [Related]
7. Preparation, characterization and biodistribution of the lactone form of 10-hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticles.
Yang L; Cui F; Cun D; Tao A; Shi K; Lin W
Int J Pharm; 2007 Aug; 340(1-2):163-72. PubMed ID: 17482779
[TBL] [Abstract][Full Text] [Related]
8. Folic acid conjugated bovine serum albumin: An efficient smart and tumor targeted biomacromolecule for inhibition folate receptor positive cancer cells.
Nosrati H; Abbasi R; Charmi J; Rakhshbahar A; Aliakbarzadeh F; Danafar H; Davaran S
Int J Biol Macromol; 2018 Oct; 117():1125-1132. PubMed ID: 29885392
[TBL] [Abstract][Full Text] [Related]
9. Folate-conjugated human serum albumin-encapsulated resveratrol nanoparticles: preparation, characterization, bioavailability and targeting of liver tumors.
Lian B; Wu M; Feng Z; Deng Y; Zhong C; Zhao X
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):154-165. PubMed ID: 30686050
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of camptothecin (CPT)-loaded folate-conjugated dextran nanoparticles for tumor-targeted drug delivery using supercritical antisolvent method.
Zhao X; Wang D; Zu Y; Jiang R; Zhao D; Li Y; Zu B; Sun Z; Zhang Q
J Control Release; 2011 Nov; 152 Suppl 1():e90-2. PubMed ID: 22195950
[No Abstract] [Full Text] [Related]
11. A novel preparation method for camptothecin (CPT) loaded folic acid conjugated dextran tumor-targeted nanoparticles.
Zu Y; Wang D; Zhao X; Jiang R; Zhang Q; Zhao D; Li Y; Zu B; Sun Z
Int J Mol Sci; 2011; 12(7):4237-49. PubMed ID: 21845075
[TBL] [Abstract][Full Text] [Related]
12. [Preparation and in vitro drug release study of long-circulating hydroxycamptothecin nanoparticles].
Xi N; Hou LB
Zhong Yao Cai; 2010 Apr; 33(4):610-3. PubMed ID: 20845792
[TBL] [Abstract][Full Text] [Related]
13. Preparation and in vitro characterization of 9-nitrocamptothecin-loaded long circulating nanoparticles for delivery in cancer patients.
Derakhshandeh K; Soheili M; Dadashzadeh S; Saghiri R
Int J Nanomedicine; 2010 Aug; 5():463-71. PubMed ID: 20957168
[TBL] [Abstract][Full Text] [Related]
14. Optimization of the preparation process of vinblastine sulfate (VBLS)-loaded folate-conjugated bovine serum albumin (BSA) nanoparticles for tumor-targeted drug delivery using response surface methodology (RSM).
Zu Y; Zhang Y; Zhao X; Zhang Q; Liu Y; Jiang R
Int J Nanomedicine; 2009; 4():321-33. PubMed ID: 20054435
[TBL] [Abstract][Full Text] [Related]
15. Hydroxycamptothecin-loaded nanoparticles enhance target drug delivery and anticancer effect.
Wang A; Li S
BMC Biotechnol; 2008 May; 8():46. PubMed ID: 18454874
[TBL] [Abstract][Full Text] [Related]
16. A novel drug-polyethylene glycol liquid compound method to prepare 10-hydroxycamptothecin loaded human serum albumin nanoparticle.
Yang Z; Gong W; Wang Z; Li B; Li M; Xie X; Zhang H; Yang Y; Li Z; Li Y; Yu F; Mei X
Int J Pharm; 2015 Jul; 490(1-2):412-28. PubMed ID: 26027489
[TBL] [Abstract][Full Text] [Related]
17. Design of fluorophore-loaded human serum albumin nanoparticles for specific targeting of NIH:OVCAR3 ovarian cancer cells.
Borlan R; Tatar AS; Soritau O; Maniu D; Marc G; Florea A; Focsan M; Astilean S
Nanotechnology; 2020 Jul; 31(31):315102. PubMed ID: 32315999
[TBL] [Abstract][Full Text] [Related]
18. Biotin/Folate-decorated Human Serum Albumin Nanoparticles of Docetaxel: Comparison of Chemically Conjugated Nanostructures and Physically Loaded Nanoparticles for Targeting of Breast Cancer.
Nateghian N; Goodarzi N; Amini M; Atyabi F; Khorramizadeh MR; Dinarvand R
Chem Biol Drug Des; 2016 Jan; 87(1):69-82. PubMed ID: 26216713
[TBL] [Abstract][Full Text] [Related]
19. Preparation, characterization, and antitumor activities of folate-decorated docetaxel-loaded human serum albumin nanoparticles.
Jiang S; Gong X; Zhao X; Zu Y
Drug Deliv; 2015 Feb; 22(2):206-13. PubMed ID: 24471890
[TBL] [Abstract][Full Text] [Related]
20. Enhanced tumor targeting and antitumor efficacy via hydroxycamptothecin-encapsulated folate-modified N-succinyl-N'-octyl chitosan micelles.
Zhu H; Cao J; Cui S; Qian Z; Gu Y
J Pharm Sci; 2013 Apr; 102(4):1318-32. PubMed ID: 23400693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
